Biotricity, Inc. (BTCY) は上場企業です ヘルスケア セクターの Medical - Devices 業界で事業展開. 本社所在地は Redwood City, CA, アメリカ. 現CEOは Waqaas Al-Siddiq.
BTCY を有する IPO日 2018-02-16, 55 名の正社員, に上場 Other OTC, 時価総額 $7.68M.
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions primarily in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.
